Global Phenylketonuria PKU Market Analysis 20112017 and Forecast 20182023 [Report Updated: 08092017] Prices from USD $2980
Snapshot
Phenylketonuria PKU is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
The global Phenylketonuria PKU market will reach xxx Million USD in 2017 and CAGR xx% 20112017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Phenylketonuria PKU by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage Market Size Forecast, Major Company of Product Type etc.:
Medications
Supplements
Others
Company Coverage Sales Revenue, Price, Gross Margin, Main Products etc.:
Biomarin
Vitaflo
Mead Johnson
Nutricia
Cambrooke
Dr. Sch?r
Prominmetabolics
PKU Perspectives
Application Coverage Market Size Forecast, Different Demand Market by Region, Main Consumer Profile etc.:
Household
Hospital
Others
Region Coverage Regional Output, Demand Forecast by Countries etc.:
North America
Europe
AsiaPacific
South America
Middle East Africa
Original Article: Global Phenylketonuria PKU Market Analysis 20112017 and Forecast 20182023 [Report Updated: 08092017] Prices from USD $2980
